Other ALS-linked proteins, such as TDP-43 and fused in sarcoma (FUS), are known to interact with the NF-κB pathway, and the inhibition of NF-κB in transgenic models overexpressing these genes ameliorated ALS-related pathological features [11,68]. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.